Carmen M Treacy
Overview
Explore the profile of Carmen M Treacy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
1085
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Prabhakar A, Kumar R, Wadhwa M, Ghatpande P, Zhang J, Zhao Z, et al.
Nat Cardiovasc Res
. 2024 Aug;
3(7):799-818.
PMID: 39196173
Pulmonary veno-occlusive disease (PVOD) is a rare form of pulmonary hypertension arising from EIF2AK4 gene mutations or mitomycin C (MMC) administration. The lack of effective PVOD therapies is compounded by...
2.
Prabhakar A, Kumar R, Wadhwa M, Ghatpande P, Zhang J, Zhao Z, et al.
bioRxiv
. 2023 Dec;
PMID: 38076809
Pulmonary veno-occlusive disease (PVOD) is a rare form of pulmonary hypertension arising from EIF2AK4 gene mutations or mitomycin C (MMC) administration. The lack of effective PVOD therapies is compounded by...
3.
Prapa M, Lago-Docampo M, Swietlik E, Montani D, Eyries M, Humbert M, et al.
Am J Respir Crit Care Med
. 2022 Jul;
206(12):1522-1533.
PMID: 35852389
Despite the increased recognition of (T-BOX transcription factor 4)-associated pulmonary arterial hypertension (PAH), genotype-phenotype associations are lacking and may provide important insights. To compile and functionally characterize all variants reported...
4.
Jones R, De Bie E, Groves E, Zalewska K, Swietlik E, Treacy C, et al.
Am J Respir Crit Care Med
. 2022 Mar;
206(1):81-93.
PMID: 35316153
Autoimmunity is believed to play a role in idiopathic pulmonary arterial hypertension (IPAH). It is not clear whether this is causative or a bystander of disease and if it carries...
5.
Schwiening M, Swietlik E, Pandya D, Burling K, Barker P, Feng O, et al.
Chest
. 2022 Jan;
161(6):1651-1656.
PMID: 35063447
No abstract available.
6.
Zhu N, Swietlik E, Welch C, Pauciulo M, Hagen J, Zhou X, et al.
Genome Med
. 2021 Jun;
13(1):106.
PMID: 34158098
No abstract available.
7.
Zhu N, Swietlik E, Welch C, Pauciulo M, Hagen J, Zhou X, et al.
Genome Med
. 2021 May;
13(1):80.
PMID: 33971972
Background: Pulmonary arterial hypertension (PAH) is a lethal vasculopathy characterized by pathogenic remodeling of pulmonary arterioles leading to increased pulmonary pressures, right ventricular hypertrophy, and heart failure. PAH can be...
8.
Swietlik E, Greene D, Zhu N, Megy K, Cogliano M, Rajaram S, et al.
Circ Genom Precis Med
. 2020 Dec;
PMID: 33320693
- Approximately 25% of patients with pulmonary arterial hypertension (PAH) have been found to harbor rare mutations in disease-causing genes. To identify missing heritability in PAH we integrated deep phenotyping...
9.
Hodgson J, Swietlik E, Salmon R, Hadinnapola C, Nikolic I, Wharton J, et al.
Am J Respir Crit Care Med
. 2019 Oct;
201(5):575-585.
PMID: 31661308
Recently, rare heterozygous mutations in were identified in patients with pulmonary arterial hypertension (PAH). encodes the circulating BMP (bone morphogenetic protein) type 9, which is a ligand for the BMP2...
10.
Sofianopoulou E, Kaptoge S, Graf S, Hadinnapola C, Treacy C, Church C, et al.
Eur Respir J
. 2019 Mar;
53(5).
PMID: 30923185
While traffic and air pollution exposure is associated with increased mortality in numerous diseases, its association with disease severity and outcomes in pulmonary arterial hypertension (PAH) remains unknown.Exposure to particulate...